These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6183686)

  • 21. Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma.
    Kim KB; Eton O; East MJ; Hodges C; Papadopoulos NE; Grimm EA; Bedikian AY
    Cancer; 2004 Aug; 101(3):596-603. PubMed ID: 15274073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of mitoxantrone by 14-day continuous infusion with granulocyte colony-stimulating factor (GCSF) support in patients with metastatic breast cancer and limited prior therapy.
    Pusztai L; Holmes FA; Fraschini G; Hortobagyi GN
    Cancer Chemother Pharmacol; 1999; 43(1):86-91. PubMed ID: 9923546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trial of weekly intensive therapy with 5-fluorouracil on two different schedules combined with interferon alpha-2a and filgrastim in patients with advanced solid tumors: Eastern Cooperative Oncology Group Study P-Z991.
    Wadler S; Atkins M; Karp D; Neuberg D; Haynes H; Dutcher JP
    Cancer J Sci Am; 1998; 4(4):261-8. PubMed ID: 9689985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
    Adis International Ltd
    Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zidovudine and interferon therapy for adult T-cell leukaemia/lymphoma. Results of a preliminary study at UHWI-Mona.
    Wharfe G; Hanchard B
    West Indian Med J; 1996 Dec; 45(4):107-9. PubMed ID: 9033228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Results of ambulatory mono- and combined interferon therapy in advanced kidney tumors].
    Buzogány I; Czvalinga I; Götz F
    Orv Hetil; 1997 Jan; 138(2):67-70. PubMed ID: 9064618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration.
    Poynard T; Leroy V; Cohard M; Thevenot T; Mathurin P; Opolon P; Zarski JP
    Hepatology; 1996 Oct; 24(4):778-89. PubMed ID: 8855176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma.
    Rohatiner A; Radford J; Deakin D; Earl H; Love SB; Price O; Wilson A; Lister TA
    Br J Cancer; 2001 Jul; 85(1):29-35. PubMed ID: 11437398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initial evaluation of human lymphoblastoid interferon in patients with advanced malignant disease.
    Priestman TJ
    Lancet; 1980 Jul; 2(8186):113-8. PubMed ID: 6157064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of leukemias and lymphomas with interferons: I. Trial of myeloma therapy with human beta-interferon].
    Misset JL; Mathé G; Gastiaburu J; Goutner A; Dorval T; Gouveia J; Hayat M; Jasmin C; Schwarzenburg L; Machover D; Ribaud P; De Vassal F; Horosezewicz JS
    Biomed Pharmacother; 1982 Jan; 36(1):55-9. PubMed ID: 6181822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic chemotherapy for metastatic melanoma.
    Mc Clay EF; Mastrangelo MJ
    Semin Oncol; 1988 Dec; 15(6):569-77. PubMed ID: 2462747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interferons--its method of administration and adverse effect related to pharmacokinetics ].
    Furue H
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):186-93. PubMed ID: 6582804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concomitant administration of recombinant human interleukin-2 and recombinant interferon alfa-2A: an active outpatient regimen in metastatic renal cell carcinoma.
    Figlin RA; Belldegrun A; Moldawer N; Zeffren J; deKernion J
    J Clin Oncol; 1992 Mar; 10(3):414-21. PubMed ID: 1482425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of interferon in the treatment of multiple myeloma].
    Shimazaki C
    Nihon Rinsho; 2006 Jul; 64(7):1291-6. PubMed ID: 16838647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of routes of administration of interferon in cancer: a review and a proposal.
    Bocci V
    Cancer Drug Deliv; 1984; 1(4):337-51. PubMed ID: 6085757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of vaccinia lesions in Rhesus monkeys by human leucocyte and fibroblast interferon.
    Weimar W; Stitz L; Billiau A; Cantell K; Schellekens H
    J Gen Virol; 1980 May; 48(1):25-30. PubMed ID: 6155433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon in metastatic renal cell carcinoma.
    Fosså SD
    Semin Oncol; 2000 Apr; 27(2):187-93. PubMed ID: 10768597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined treatment of metastatic melanoma with interferons and cytotoxic drugs.
    Garbe C; Kreuser ED; Zouboulis CC; Stadler R; Orfanos CE
    Semin Oncol; 1992 Apr; 19(2 Suppl 4):63-9. PubMed ID: 1372765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antitumor activity of human interferons: their direct cytotoxic activity and clinical effects].
    Shimoyama M; Yamada H; Kitahara T; Adachi I; Yoshida S; Okazaki N; Tobinai K; Konda C; Kakizoe T; Matsumoto K; Ise T; Ichikawa H
    Gan No Rinsho; 1983 May; 29(6):589-97. PubMed ID: 6192265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combination of interferon-alpha with cytostatic drugs: a potentially successful therapeutic approach in metastatic melanoma].
    Garbe C; Zouboulis CC; Krüger S; Waibel M; Kreuser ED; Stadler R; Orfanos CE
    Hautarzt; 1992 Jan; 43(1):4-10. PubMed ID: 1369746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.